Literature DB >> 1125686

Letter: Serum muramidase activity in untreated cancer.

W W Jedrzejczak, M Siekierzynski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1125686      PMCID: PMC1672735          DOI: 10.1136/bmj.1.5960.735-c

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid.

Authors:  B H Park; S M Fikrig; E M Smithwick
Journal:  Lancet       Date:  1968-09-07       Impact factor: 79.321

2.  Plasma lysozyme in drug-induced and spontaneous cyclic neutropenia.

Authors:  N E Hansen; V Andersen; H Karle
Journal:  Br J Haematol       Date:  1973-10       Impact factor: 6.998

3.  Serum lysozyme (muramidase) as functional test of granulopoiesis in the course of cytostatic therapy.

Authors:  S Szmigielski; A Okninska; J Ostojska; J Moneta
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1974

4.  Periodic hematopoiesis in human cyclic neutropenia.

Authors:  D Guerry; D C Dale; M Omine; S Perry; S M Wolff
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

  4 in total
  1 in total

1.  Serum lysozyme as a marker of host resistance. II. Patients with malignant melanoma, hypernephroma or breast carcinoma.

Authors:  G A Currie
Journal:  Br J Cancer       Date:  1976-06       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.